246 related articles for article (PubMed ID: 22566240)
1. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction.
Zhang S; Zheng R; Yang L; Zhang X; Zuo L; Yang X; Bai K; Song L; Tian J; Yang J; Liu H
J Cell Physiol; 2013 Jan; 228(1):142-8. PubMed ID: 22566240
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody against angiotensin AT1 receptor from preeclamptic patients enhances collagen-induced human platelet aggregation.
Bai K; Wang K; Li X; Wang J; Zhang J; Song L; Wang J; Zhang S; Lau WB; Ma X; Liu H
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):749-55. PubMed ID: 23681235
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor.
Yang X; Wang F; Lau WB; Zhang S; Zhang S; Liu H; Ma XL
Cardiovasc Toxicol; 2014 Mar; 14(1):21-9. PubMed ID: 24122090
[TBL] [Abstract][Full Text] [Related]
5. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation.
Thway TM; Shlykov SG; Day MC; Sanborn BM; Gilstrap LC; Xia Y; Kellems RE
Circulation; 2004 Sep; 110(12):1612-9. PubMed ID: 15381659
[TBL] [Abstract][Full Text] [Related]
6. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion.
Bobst SM; Day MC; Gilstrap LC; Xia Y; Kellems RE
Am J Hypertens; 2005 Mar; 18(3):330-6. PubMed ID: 15797649
[TBL] [Abstract][Full Text] [Related]
7. Limited AT1 Receptor Internalization Is a Novel Mechanism Underlying Sustained Vasoconstriction Induced by AT1 Receptor Autoantibody From Preeclampsia.
Bian J; Lei J; Yin X; Wang P; Wu Y; Yang X; Wang L; Zhang S; Liu H; Fu MLX
J Am Heart Assoc; 2019 Mar; 8(6):e011179. PubMed ID: 30845870
[TBL] [Abstract][Full Text] [Related]
8. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.
Dechend R; Viedt C; Müller DN; Ugele B; Brandes RP; Wallukat G; Park JK; Janke J; Barta P; Theuer J; Fiebeler A; Homuth V; Dietz R; Haller H; Kreuzer J; Luft FC
Circulation; 2003 Apr; 107(12):1632-9. PubMed ID: 12668498
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
Knock GA; Sullivan MH; McCarthy A; Elder MG; Polak JM; Wharton J
J Pharmacol Exp Ther; 1994 Nov; 271(2):1007-15. PubMed ID: 7965763
[TBL] [Abstract][Full Text] [Related]
10. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells.
Xia Y; Wen H; Bobst S; Day MC; Kellems RE
J Soc Gynecol Investig; 2003 Feb; 10(2):82-93. PubMed ID: 12593997
[TBL] [Abstract][Full Text] [Related]
11. Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?
Ye Y; Kong Y; Zhang Y
Gynecol Obstet Invest; 2016; 81(1):28-33. PubMed ID: 26485247
[TBL] [Abstract][Full Text] [Related]
12. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia.
Wallukat G; Neichel D; Nissen E; Homuth V; Luft FC
Can J Physiol Pharmacol; 2003 Feb; 81(2):79-83. PubMed ID: 12710518
[TBL] [Abstract][Full Text] [Related]
13. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-α.
Chai W; Zhang W; Jin Z; Feng Y; Kuang Y; Zhi J
Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):984-90. PubMed ID: 23089979
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
Herse F; Verlohren S; Wenzel K; Pape J; Muller DN; Modrow S; Wallukat G; Luft FC; Redman CW; Dechend R
Hypertension; 2009 Feb; 53(2):393-8. PubMed ID: 19064815
[TBL] [Abstract][Full Text] [Related]
16. [Endothelin 1 and angiotensin II in preeeclampsia].
Ariza AC; Bobadilla NA; Halhali A
Rev Invest Clin; 2007; 59(1):48-56. PubMed ID: 17569300
[TBL] [Abstract][Full Text] [Related]
17. Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.
Regal JF; Strehlke ME; Peterson JM; Wing CR; Parker JE; Nieto NF; Bemis LT; Gilbert JS; Fleming SD
Mol Immunol; 2016 Oct; 78():38-47. PubMed ID: 27588825
[TBL] [Abstract][Full Text] [Related]
18. Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.
Cunningham MW; Williams JM; Amaral L; Usry N; Wallukat G; Dechend R; LaMarca B
Hypertension; 2016 Nov; 68(5):1308-1313. PubMed ID: 27698062
[TBL] [Abstract][Full Text] [Related]
19. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.
LaMarca B; Parrish M; Ray LF; Murphy SR; Roberts L; Glover P; Wallukat G; Wenzel K; Cockrell K; Martin JN; Ryan MJ; Dechend R
Hypertension; 2009 Oct; 54(4):905-9. PubMed ID: 19704104
[TBL] [Abstract][Full Text] [Related]
20. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.
Stepan H; Faber R; Wessel N; Wallukat G; Schultheiss HP; Walther T
J Clin Endocrinol Metab; 2006 Jun; 91(6):2424-7. PubMed ID: 16569734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
